LUNG TRANSPLANTATION - ADULT (LTX) -> LTX - Donor Management and Organ Allocation Abstracts

457 - Survival Outcomes of Lung Transplant Recipients from Donors with High Body Mass Index

Presentation Number
457
Speakers
Session Name
MINI ORAL 10 - MINI ORAL SESSION: Survival Determinants and Assessment Tools Post Lung Transplantation
Date
Thu, Apr 23, 2020
Time
06:15 PM - 07:15 PM
Authors

Previous ePresentation
456 - Survival Outcomes of Lung Transplant Recipients from Donors with Abnormal Kidney Function

Next ePresentations
466 - Complement Inhibition as Potential Novel Therapy for Antibody-Mediated Rejection after Lung Transplantation in Murine Antibody-Mediated Rejection Model
478 - Incidence of Driveline Infections and Sepsis in a Contemporary HVAD Population
481 - Acute Infection Disrupts the Respiratory Microbiome of Lung Transplant Recipients
485 - Recombinant Herpes Zoster Vaccine (RZV) after Heart Transplantation: A Single Center Experience
489 - Clinical Outcomes after Pediatric Lung Transplantation at Cystic Fibrosis Care Centers
491 - Tacrolimus Trough Variability- Predictors and Outcomes in Pediatric Heart Transplantation
493 - Gene Expression Profiling Scores (Allomap) Can Successfully Predict the Absence of Serious Rejection in a Pediatric Heart Transplant Population; Single Center Experience
495 - Health-Related Quality of Life Differs by Pre-Operative Implant Strategy from before through Mid-Term after Surgery: Findings from INTERMACS
496 - Advances in Driveline Technology Cures Some but Infects Others: Single Center's Experience with Driveline Infections in HeartMate 3 Patients
501 - Immune Checkpoint Inhibitors in Thoracic Transplant Recipients: A Registry Initiative